ArticleMalaria journal2026
Comparative evaluation of multiplex bead assay, polymerase chain reaction, and rapid diagnostic test for P. falciparum detection in community surveys in Malawi.
Article in Malaria journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundAccurate detection of malaria infections, particularly asymptomatic and low-density infections, is essential for effective surveillance and control efforts. This study compared the performance of three malaria detection platforms for identifying Plasmodium falciparum infections in a community-based survey setting.
methodsCross-sectional household surveys were conducted in three high-transmission districts in Malawi from February-March in 2022 and 2023. From 2960 participants, samples from 604 children aged 2 months to 14 years were analyzed for P. falciparum infection using three detection methods: WHO-prequalified HRP2-based rapid diagnostic tests (RDTs), a multiplex bead-based assay (MBA) for histidine-rich protein 2 (HRP2) and Plasmodium lactate dehydrogenase (pLDH) antigens, and a real-time quantitative polymerase chain reaction (PCR) targeting P. falciparum 18S rRNA, which was considered the gold standard test.
resultsPCR detected a P. falciparum prevalence of 24.0% (145/604; 95% CI 20.7-27.6%) compared to 29.5% by RDT (178/604; 95% CI 25.9-33.3%). RDT performance was suboptimal compared to PCR, with RDT sensitivity of 48.3% (95% CI 39.9-56.7%) and specificity of 76.5% (95% CI 72.3-80.3%). Seventy-five PCR-positive samples were RDT-negative, possibly representing low-density infections below RDT detection limits, while 108 RDT-positive samples were PCR-negative, consistent with persistent HRP2 antigenemia following parasite clearance. Receiver operating curve analyses demonstrated that the MBA for both antigens showed limited discriminatory power against PCR, HRP2 (AUC = 0.63, 95% CI 0.58-0.69) and pLDH (AUC = 0.61, 95% CI 0.56-0.67). However, MBA demonstrated strong agreement with RDTs, (HRP2: AUC = 0.93 (95% CI 0.90-0.96); pLDH: AUC = 0.88, (95% CI 0.85-0.92), indicating comparable antigen detection capabilities. PCR was estimated to be 41.3% less expensive in start-up costs and 32.2% less in processing costs compared to the MBA.
conclusionsIn high-transmission, community-based settings, the malaria antigen detection MBA demonstrated a limited ability to detect P. falciparum infections when compared to infection identified by PCR. Real-time PCR is increasingly feasible for use in surveillance where infrastructure permits. These findings underscore the importance of selecting diagnostic tools based on surveillance objectives, local epidemiology, and available laboratory capacity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.